Pharma Journalist -

Novartis announced updated median overall survival (OS) results for Kisqali (ribociclib) in combination with endocrine therapy, marking the longest survival data ever reported in…
Read More...

Boehringer Ingelheim announced the execution of the agreement on the acquisition of Labor Dr. Merk & Kollegen. The acquisition will enable Boehringer Ingelheim to further expand and…
Read More...

Intec Pharma Ltd. announces it has entered into a feasibility agreement with GW Research Limited ("GW"), London, U.K. to explore using the Accordion Pill (AP) platform for an…
Read More...

InveniAI LLC, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across drug discovery and development, and…
Read More...

Global contract development and manufacturing organisation (CDMO), Recipharm, has announced an investment and capacity expansion at its facility in Israel. This investment will support…
Read More...

Sinovac Biotech Ltd. announced that the China National Medical Products Administration (NMPA) has approved and issued a Product license for the Company’s 23-Valent Pneumococcal…
Read More...

Thermo Fisher Scientific announced it will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical…
Read More...

Arcus Biosciences, Inc. and WuXi Biologics announced an expansion of their existing strategic relationship under which the parties will discover anti-CD39 antibodies using WuXi Bio’s…
Read More...

Amgen announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for its investigational KRASG12C inhibitor, sotorasib, for the treatment of…
Read More...

Applied BioMath announced a collaboration with Antengene Corporation for the development of a systems pharmacology modeling in immuno-oncology. Applied BioMath will develop a systems…
Read More...